RUBICON BIOTECHNOLOGY LLC
Biotech · Private
Cell-penetrating antibody fusion protein (Fv-Hsp70) for intracellular heat shock protein delivery to prevent retinal cell death
rubiconbio.com →- Grants
- $1.0M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 8
- 0 granted · 8 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2015201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Modified Annexin V for immunostimulation of the tumor microenvironment | $292,989 | |
| Federal grant | Department of Health and Human Services · Phase I · Modified Annexin V for immunostimulation of the tumor microenvironment | $292,989 | |
| Federal grant | Department of Health and Human Services · Phase I · Targeted Hsp72 as a Therapeutic for Central Retinal Artery Occlusion | $212,466 | |
| Federal grant | Department of Health and Human Services · Phase I · Targeted Hsp as a Therapeutic for Central Retinal Artery Occlusion | $212,466 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1549 | KESHAVA BIOSCIENCES LLC | — | — |
| 1550 | MAGIC BLUE, LLC | — | — |
| 1551 | VISHENARY, LLC | — | — |
| 1552 | RUBICON BIOTECHNOLOGY LLC | — | — |
| 1553 | ALISBIO LLC | — | — |
| 1554 | BORAGEN INC | — | — |
| 1555 | CELLINFINITY BIO, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Modified Heat Shock Proteinsapplication
- Cancer Immunotherapeuticapplication
- Methods For Using FV-HPS72 For Treating Injuryapplication
- Modified Heat Shock Proteinsapplication
- Cancer Immunotherapeuticapplication
- Methods For Using FV-HSP72 For Treating Injuryapplication
- Cancer Immunotherapeuticapplication
- Methods For Using FV-HPS72 For Treating Injuryapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.